Intriguingly, using sorted differentiated CD133–FLUO–cancer cells, overexpression of NR5A2 induced upregulation of CD133 and CXCR4 (Fig. S4F), enhanced sphere formation (Fig. S4G), and, most importantly, markedly enhanced in vivo tumorigenicity (Fig. 5G). This evidence concerns the gene PROM1 and cancer.